Promising preclinical data for SIG-005 encapsulated nonviral cell-based therapy for MPS Feb. 15, 2021
New phase I/II study evaluates hLB-001 in pediatric patients with severe methylmalonic acidemia Feb. 15, 2021
Incyte begins phase II study with retifanlimab in advanced or metastatic endometrial cancer Feb. 15, 2021
AC Immune reports interim data from phase Ib/II study of anti-pTau vaccine candidate ACI-35.030 Feb. 12, 2021